Clinical Trial Update: Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of docetaxel, doxorubicin, and cyclophosphamide for advanced breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)
• Doxorubicin (doxorubicin)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 1 | Status: WITHDRAWN